Global Trends & Drivers:
The precision medicine market has witnessed a significant expansion in research and development activities, especially following the COVID-19 pandemic. The pandemic underscored the necessity for individualized treatment regimes, leading to increased investments in precision medicine. The shift towards integrating cell and gene therapies, coupled with regulatory approvals for novel treatments, further signals promising growth prospects.
Regional Insights:
North America remains at the forefront, dominating the market with a share of 50.91% in 2023. This dominance is attributed to the region’s advanced healthcare infrastructure and a high incidence of chronic diseases, such as cancer, which propels the demand for personalized treatments. According to the 
AI: A Revolutionary Force in Property Valuation
The advent of Artificial Intelligence (AI) has ushered in a new era in the realm of property valuation and appraisal. AI, a formidable tool capable of swiftly analyzing vast amounts of data, provides real-time insights into property values. However, the importance of human expertise in interpreting data and making informed judgments cannot be undermined. A blend of AI and human judgment ensures accurate and reliable property valuations. AI has also made significant strides in the development of valuation products for Home Equity Lines of Credit (HELOCs) and second-lien mortgages. These products leverage AI technology to assess risk more effectively, providing lenders with a comprehensive understanding of the property's value. As AI continues to evolve, we can expect further advancements in the property valuation and appraisal process. The future of property valuations lies in the synergy between AI and human expertise, ensuring accurate, reliable, and contextually informed property valuations.
